185 related articles for article (PubMed ID: 18680522)
41. Biochemical and functional characterization of triosephosphate isomerase from Mycobacterium tuberculosis H37Rv.
Mathur D; Malik G; Garg LC
FEMS Microbiol Lett; 2006 Oct; 263(2):229-35. PubMed ID: 16978361
[TBL] [Abstract][Full Text] [Related]
42. Validation of molecular docking programs for virtual screening against dihydropteroate synthase.
Hevener KE; Zhao W; Ball DM; Babaoglu K; Qi J; White SW; Lee RE
J Chem Inf Model; 2009 Feb; 49(2):444-60. PubMed ID: 19434845
[TBL] [Abstract][Full Text] [Related]
43. Structural and thermodynamic insights into the binding mode of five novel inhibitors of lumazine synthase from Mycobacterium tuberculosis.
Morgunova E; Illarionov B; Sambaiah T; Haase I; Bacher A; Cushman M; Fischer M; Ladenstein R
FEBS J; 2006 Oct; 273(20):4790-804. PubMed ID: 16984393
[TBL] [Abstract][Full Text] [Related]
44. Structure-function analysis of the acyl carrier protein synthase (AcpS) from Mycobacterium tuberculosis.
Dym O; Albeck S; Peleg Y; Schwarz A; Shakked Z; Burstein Y; Zimhony O
J Mol Biol; 2009 Nov; 393(4):937-50. PubMed ID: 19733180
[TBL] [Abstract][Full Text] [Related]
45. Cloning, sequencing, and enhanced expression of the dihydropteroate synthase gene of Escherichia coli MC4100.
Dallas WS; Gowen JE; Ray PH; Cox MJ; Dev IK
J Bacteriol; 1992 Sep; 174(18):5961-70. PubMed ID: 1522070
[TBL] [Abstract][Full Text] [Related]
46. Novel and potent inhibitors for dihydropteroate synthase of
Satuluri SH; Katari SK; Pasala C; Amineni U
J Recept Signal Transduct Res; 2020 Jun; 40(3):246-256. PubMed ID: 32098568
[TBL] [Abstract][Full Text] [Related]
47. Computational insights into factor affecting the potency of diaryl sulfone analogs as Escherichia coli dihydropteroate synthase inhibitors.
Das BK; Pv P; Chakraborty D
Comput Biol Chem; 2019 Feb; 78():37-52. PubMed ID: 30497019
[TBL] [Abstract][Full Text] [Related]
48. Expression and functional analysis of a predicted AtsG arylsulphatase identified from Mycobacterium tuberculosis genomic data.
Hossain MM; Kawarabayasi Y; Kimura M; Kakuta Y
J Biochem; 2009 Dec; 146(6):767-9. PubMed ID: 19734177
[TBL] [Abstract][Full Text] [Related]
49. Targeting intracellular p-aminobenzoic acid production potentiates the anti-tubercular action of antifolates.
Thiede JM; Kordus SL; Turman BJ; Buonomo JA; Aldrich CC; Minato Y; Baughn AD
Sci Rep; 2016 Dec; 6():38083. PubMed ID: 27905500
[TBL] [Abstract][Full Text] [Related]
50. Development of a pterin-based fluorescent probe for screening dihydropteroate synthase.
Zhao Y; Hammoudeh D; Lin W; Das S; Yun MK; Li Z; Griffith E; Chen T; White SW; Lee RE
Bioconjug Chem; 2011 Oct; 22(10):2110-7. PubMed ID: 21916405
[TBL] [Abstract][Full Text] [Related]
51. Structure-based design and development of functionalized Mercaptoguanine derivatives as inhibitors of the folate biosynthesis pathway enzyme 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase from Staphylococcus aureus.
Dennis ML; Chhabra S; Wang ZC; Debono A; Dolezal O; Newman J; Pitcher NP; Rahmani R; Cleary B; Barlow N; Hattarki M; Graham B; Peat TS; Baell JB; Swarbrick JD
J Med Chem; 2014 Nov; 57(22):9612-26. PubMed ID: 25357262
[TBL] [Abstract][Full Text] [Related]
52. Sulfonamide resistance: mechanisms and trends.
Sköld O
Drug Resist Updat; 2000 Jun; 3(3):155-160. PubMed ID: 11498380
[TBL] [Abstract][Full Text] [Related]
53. Analysis of random mutations in Salmonella Gallinarum dihydropteroate synthase conferring sulfonamide resistance.
Duysak T; Jeong JH; Kim K; Kim JS; Choy HE
Arch Microbiol; 2023 Oct; 205(12):363. PubMed ID: 37906281
[TBL] [Abstract][Full Text] [Related]
54. Insights into the drug resistance induced by the BaDHPS mutations: molecular dynamic simulations and MM/GBSA studies.
Chu WT; Zhang JL; Zheng QC; Chen L; Xue Q; Zhang HX
J Biomol Struct Dyn; 2013 Oct; 31(10):1127-36. PubMed ID: 23030549
[TBL] [Abstract][Full Text] [Related]
55. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
56. Binding Isotope Effects for para-Aminobenzoic Acid with Dihydropteroate Synthase from Staphylococcus aureus and Plasmodium falciparum.
Stratton CF; Namanja-Magliano HA; Cameron SA; Schramm VL
ACS Chem Biol; 2015 Oct; 10(10):2182-6. PubMed ID: 26288086
[TBL] [Abstract][Full Text] [Related]
57. The aminosalicylate - folate connection.
London RE
Drug Metab Rev; 2024 Feb; 56(1):80-96. PubMed ID: 38230664
[TBL] [Abstract][Full Text] [Related]
58. Inhibition studies of sulfonamide-containing folate analogs in yeast.
Patel O; Satchell J; Baell J; Fernley R; Coloe P; Macreadie I
Microb Drug Resist; 2003; 9(2):139-46. PubMed ID: 12820798
[TBL] [Abstract][Full Text] [Related]
59. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
60. Dynamic and structural characterization of a bacterial FHA protein reveals a new autoinhibition mechanism.
Barthe P; Roumestand C; Canova MJ; Kremer L; Hurard C; Molle V; Cohen-Gonsaud M
Structure; 2009 Apr; 17(4):568-78. PubMed ID: 19368890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
